Compare Serum Klotho Levels in Patients on Oral Antidiabetic Treatment
NCT03585777 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2018-07-13
Summary
Klotho is a protein found in serum, kidney,heart,brain and in other tissues,it has many functions,it is viewed as the anti aging hormone. Aging kidneys are characterized by progressive scarring and measurable declines in renal function
Conditions
- Compare Serum Level of Klotho in Patients on Oral Antidiabetic Treatment
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-11
- Primary Completion
- 2019-01-31
- Completion
- 2019-03-31
Countries
- Egypt
Study Locations
More Related Trials
-
Nitric Oxide (NO) Activity and Diabetic Nephropathy
NCT00136188 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
NCT01131091 ·Status: COMPLETED ·Phase: PHASE1
-
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients with Type 2 Diabetes and CKD
NCT06820567 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
NCT06049550 ·Status: UNKNOWN
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06802978 ·Status: RECRUITING
-
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
NCT03573102 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
NCT01581658 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency
NCT06883656 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
NCT06897605 ·Status: RECRUITING ·Phase: PHASE2
-
SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?
NCT04853615 ·Status: UNKNOWN
-
OPTIMISE-CKD Drug Utilization
NCT05932901 ·Status: COMPLETED
-
Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
NCT01835678 ·Status: COMPLETED ·Phase: PHASE3
-
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
NCT06421870 ·Status: RECRUITING ·Phase: PHASE3
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
NCT06278207 ·Status: RECRUITING
-
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
NCT05705271 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
NCT05735197 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
NCT06982079 ·Status: RECRUITING ·Phase: PHASE3
-
Adiponectin and Insulin Resistance in Diabetic Nephropathy
NCT00774904 ·Status: COMPLETED ·Phase: NA
-
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
NCT06222476 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk
NCT01213212 ·Status: COMPLETED ·Phase: PHASE2
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
NCT06398977 ·Status: RECRUITING ·Phase: NA